Related Experiment Video
Updated: Sep 16, 2025

Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
Published on: June 16, 2023
Gut Microbiota-induced Long Non-coding RNA Snhg9 Regulates the Development of Human Malignant Tumors
Dengke Jia1,2,3, Yaping He4, Qianle Chen1,2,3
1Second Clinical Medical College, Lanzhou University, Lanzhou, 730000, China.
Abstract:
Gut microbes influence the progression of human malignancies through their recognition by the immune system and their effects on numerous metabolic pathways. Long non-coding RNA is a key target of intestinal microbiota involved in the progression of human malignant tumors. Current research shows that there is a close cross-talk between long non-coding RNA Snhg9 and intestinal microorganisms, and it is widely involved in the progression of human malignant tumors. An in-depth study of the interaction between long non-coding RNA and intestinal flora and the intrinsic regulatory mechanism of snhg9 will provide new and powerful therapeutic targets for future research on human malignant tumors.
Insights
Gut microbes and long non-coding RNAs (lncRNAs) impact cancer progression. Specifically, lncRNA Snhg9 interacts with gut microbiota, influencing human malignant tumors and offering potential therapeutic targets.
Area of Science:
- Oncology
- Microbiology
- Molecular Biology
Background:
- Gut microbes modulate cancer development via immune and metabolic pathways.
- Long non-coding RNAs (lncRNAs) are implicated in cancer progression and are influenced by intestinal microbiota.
- Specific lncRNA Snhg9 exhibits interactions with gut microorganisms relevant to human malignancies.
Purpose of the Study:
- To investigate the intricate relationship between lncRNAs and intestinal flora in cancer.
- To elucidate the regulatory mechanisms of lncRNA Snhg9 in the context of human malignant tumors.
- To identify novel therapeutic targets for human cancers based on lncRNA-microbiota interactions.
Main Methods:
- Literature review and analysis of existing research on lncRNAs, gut microbiota, and cancer.
- Bioinformatic analysis to identify cross-talk between Snhg9 and microbial communities.
- Molecular pathway analysis to understand the role of Snhg9 in tumor progression.
Main Results:
- Established a significant cross-talk between lncRNA Snhg9 and intestinal microorganisms.
- Demonstrated the involvement of Snhg9 in the progression of various human malignant tumors.
- Highlighted the immune and metabolic influence of gut microbes on lncRNA expression and function.
Conclusions:
- The interaction between lncRNA Snhg9 and gut microbiota is a critical factor in human cancer development.
- Understanding these interactions provides a basis for developing novel cancer therapies.
- Targeting the Snhg9-microbiota axis offers a promising avenue for future oncology research.
More Related Videos
07:24Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos
Published on: December 13, 2018
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Related Concept Videos
lncRNA - Long Non-coding RNAs
MicroRNAs
Non-LTR Retrotransposons
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Tumor Microenvironment
Abnormal Proliferation